President and CFO of Cara Therapeutics, Inc. (NASDAQ:CARA), Posner Christopher, sells 2,000 shares worth $31,638

According to Cara Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 23 08:28 PM, company President and CFO, Posner Christopher disclosed selling 2,000 shares at a cost of $15.82. At the time of this transaction (Nov 19), this trade was worth $31,638 in total. As of Nov 19, Posner Christopher now owns 11,200 shares in total worth about $167,888.0.

For the last few recent trades made by Cara Therapeutics, Inc. (NASDAQ:CARA) President and CFO, Posner Christopher, we have the following information:

    Posted by on Monday November 23 2020, 11:24 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

    Comments are closed

    Featured Press Releases

    Log in